About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
CBAY
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- CymaBay Therapeutics GAAP EPS of -$0.28 beats by $0.02
- CymaBay Therapeutics Q3 2022 Earnings Preview
- CymaBay Therapeutics GAAP EPS of -$0.31 misses by $0.01
- CymaBay Therapeutics Q2 2022 Earnings Preview
- GH, FUV and CBAY among after hour movers.
- CymaBay Therapeutics stock gains after CEO buys shares worth $100K
- CymaBay announces result from two-year study of primary biliary cholangitis therapy
- CymaBay price target lowered at H.C. Wainwright on enrollment delay for key study
- CymaBay Therapeutics GAAP EPS of -$0.32 misses by $0.01
- CymaBay Therapeutics Q1 2022 Earnings Preview
- CymaBay announces result from Phase 2 trial of primary biliary cholangitis therapy
- CymaBay Therapeutics GAAP EPS of -$0.34 misses by $0.11
- CymaBay Therapeutics Q4 2021 Earnings Preview
- CymaBay on the rise after insider purchase of chief medical officer
- CymaBay Therapeutics prices ~$75M offering
- CymaBay Therapeutics announces public offering of common stock and warrants
- CymaBay Therapeutics shares long-term bio marker data for liver disease therapy
- CymaBay Therapeutics EPS misses by $0.08
- CymaBay Therapeutics Q3 2021 Earnings Preview
- CymaBay Therapeutics EPS misses by $0.07
PEERS
| Date | Price | Open | High | Low | Vol | ER | |||
|---|---|---|---|---|---|---|---|---|---|
| Mar 23 | 3.240 | 3.360 |
3.400
|
3.230
|
303.88K | ||||
| Mar 22 | 3.390 | 3.210 |
3.405
|
3.170
|
464.99K | ||||
| Mar 21 | 3.210 | 3.180 |
3.310
|
3.179
|
467.94K | ||||
| Mar 18 | 3.150 | 3.180 |
3.540
|
3.110
|
2.33M | ||||
| Mar 17 | 3.180 | 3.040 |
3.200
|
3.035
|
563.29K | ||||
| Mar 16 | 3.050 | 3.050 |
3.110
|
2.935
|
524.29K | ||||
| Mar 15 | 2.970 | 3.000 |
3.040
|
2.910
|
320.61K | ||||
| Mar 14 | 2.970 | 3.230 |
3.230
|
2.940
|
427.46K | ||||
| Mar 11 | 3.210 | 3.340 |
3.390
|
3.210
|
238.49K | ||||
| Mar 10 | 3.330 | 3.350 |
3.410
|
3.285
|
276.44K | ||||
| Mar 9 | 3.400 | 3.210 |
3.410
|
3.200
|
338.28K | ||||
| Mar 8 | 3.180 | 3.150 |
3.250
|
3.090
|
205.97K | ||||
| Mar 7 | 3.150 | 3.140 |
3.245
|
3.075
|
338.63K | ||||
| Mar 4 | 3.130 | 3.130 |
3.229
|
3.105
|
232.48K | ||||
| Mar 3 | 3.160 | 3.280 |
3.310
|
3.100
|
223.73K | ||||
| Mar 2 | 3.250 | 3.290 |
3.290
|
3.195
|
206.63K | ||||
| Mar 1 | 3.270 | 3.170 |
3.300
|
3.170
|
235.67K | ||||
| Feb 28 | 3.180 | 3.190 |
3.270
|
3.160
|
333.15K | ||||
| Feb 25 | 3.230 | 3.240 |
3.255
|
3.140
|
261.44K | ||||
| Feb 24 | 3.220 | 3.070 |
3.260
|
3.010
|
442.41K | ||||